We are live on ! Find out more
SXL

Summit X LLC Portfolio holdings

AUM $536M
1-Year Est. Return 15.36%
This Fund
S&P 500
This Quarter Est. Return
+9.52%
1 Year Est. Return
+15.36%
3 Year Est. Return
+62.88%
5 Year Est. Return
+106.61%
10 Year Est. Return
AUM
$352M
AUM Growth
+$36.5M
Cap. Flow
+$7.88M
Cap. Flow %
2.24%
Top 10 Hldgs %
45.43%
Holding
197
New
16
Increased
86
Reduced
78
Closed
7
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SDY icon
176
State Street SPDR S&P Dividend ETF
SDY
$21.9B
$216K 0.06%
1,730
-69
-4% -$8.1K
ARTY
177
iShares Future AI & Tech ETF
ARTY
$3.46B
$213K 0.06%
+6,160
New +$195K
IGSB icon
178
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.8B
$208K 0.06%
+2,018
New +$101K
AIQ icon
179
Global X Artificial Intelligence & Technology ETF
AIQ
$9.44B
$205K 0.06%
+6,588
New +$188K
VLUE icon
180
iShares MSCI USA Value Factor ETF
VLUE
$9.63B
$205K 0.06%
+2,028
New +$189K
IWR icon
181
iShares Russell Mid-Cap ETF
IWR
$57B
$202K 0.06%
+2,566
New +$182K
CVX icon
182
Chevron
CVX
$366B
$201K 0.06%
1,349
+51
+4% +$7.71K
PMF
183
DELISTED
PIMCO Municipal Income Fund
PMF
$189K 0.05%
20,248
+1,188
+6% +$10.3K
T icon
184
AT&T
T
$153B
$187K 0.05%
11,121
-798
-7% -$12.6K
RVNC
185
DELISTED
Revance Therapeutics, Inc.
RVNC
$153K 0.04%
17,388
-257
-1% -$2.11K
INVZ icon
186
Innoviz Technologies
INVZ
$138M
$119K 0.03%
47,020
+2,001
+4% +$3.83K
MESO
187
Mesoblast
MESO
$2.31B
$34.1K 0.01%
15,506
+1,501
+11% +$3.58K
HYPR icon
188
Hyperfine
HYPR
$97.5M
$20.2K 0.01%
+18,000
New +$25K
TRVN
189
DELISTED
Trevena, Inc.
TRVN
$11.8K ﹤0.01%
656
SER icon
190
Serina Therapeutics
SER
$29.7M
$8.66K ﹤0.01%
640
-412
-39% -$7.58K
AVDE icon
191
Avantis International Equity ETF
AVDE
$17.5B
-8,103
Closed -$451K
FDHY icon
192
Fidelity High Yield Factor ETF
FDHY
$565M
-13,341
Closed -$610K
FDVV icon
193
Fidelity High Dividend ETF
FDVV
$10.1B
-17,525
Closed -$676K
FHLC icon
194
Fidelity MSCI Health Care Index ETF
FHLC
$3.29B
-4,627
Closed -$280K
IDV icon
195
iShares International Select Dividend ETF
IDV
$8.23B
-11,811
Closed -$300K
LCTX icon
196
Lineage Cell Therapeutics
LCTX
$292M
-10,925
Closed -$12.9K
SPMD icon
197
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$18.2B
-66,083
Closed -$2.89M

Similar funds

Summit X LLC's Q4 2023 Portfolio in Review

As of Q4 2023, Summit X LLC held 197 positions worth $352M, up 12% from $315M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Summit X LLC's Q4 2023 filing shows 16 new, 86 increased, 78 reduced and 7 closed positions. Its largest new stake was Vanguard Mega Cap 300 Index ETF: 24,718 shares worth $4.18M. The largest sale was State Street SPDR Portfolio S&P 400 Mid Cap ETF, an estimated $2.89M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Summit X LLC's largest Q4 2023 buy was Vanguard Mega Cap 300 Index ETF: 24,718 shares worth $4.18M.
  • Summit X LLC added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $5.09M increase.
  • Summit X LLC's biggest Q4 2023 reduction was iShares MSCI EAFE Growth ETF, cutting an estimated $2.64M.
  • Summit X LLC fully exited State Street SPDR Portfolio S&P 400 Mid Cap ETF in Q4 2023, selling an estimated $2.89M.
  • Summit X LLC's ten largest holdings make up 45% of its $352M portfolio in Q4 2023.
  • Summit X LLC opened 16 new positions and closed 7 in Q4 2023.
  • Summit X LLC's portfolio value rose 12% quarter-over-quarter to $352M.

Based on Summit X LLC's 13F filing for Q4 2023, filed 8 Feb 2024.